Earlier Detection Of Parkinson’s Disease Getting Much Closer Say Researchers
Based on close co-operation between a Roche medical chemist Ludmilla Morozova, the research team at Umeå University lead by Lars Forsgren, and a team at Oxford University lead by Jason Davis doctors may be able to soon detect Parkinson’s disease at a much earlier stage.
It was back in 2011 when the Umeå scientists were able to determine endogenous antibodies against the most important amyloid protein, alpha-synuclein. Amyloids are created when proteins are lumped together and then in the case of Parkinson’s attack the nervous system.
These antibodies are seen as being able to function as a diagnostic marker making it easier to detect the disease at an earlier stage than before. This is accomplished using a simplified way to measure the contents of antibodies in a blood sample and with this new way it is possible to see a clear difference between individuals with incipient Parkinson’s and the healthy controls. Additionally this method can be used to measure and establish the advance of the disease with much greater accuracy.
via Phys.org
Comments
About the Author
Steven Hodson Steven has been around the tech world long enough to see most of the stuff we think of cool happen before which leads to a certain bit of cynicism that has contributed to him being known as the cranky old fart of the Internet. Besides sharing some of the goodness that he finds with you here at 42x you can also find him curating some digital goodness at Winextra (tech type stuff) and Rotten Gumdrops (for your daily dose of WTF).
Related Posts
Your Dentist Could Soon Use Your Saliva To Diagnose Cancer →
Pediatric Medicaid Patients Being Accepted By Fewer Orthopedic Surgeons →
The Anthrax Bacteria Throws A Scary Surprise At Scientists →
